109 results
424B5
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Prospectus supplement for primary offering
4:52pm
program will ultimately save time, resources, and money. In so doing, we believe that AI-POWR™ is a risk-mitigation strategy that should reap benefits … . In so doing, we believe that AI-POWR™ is a risk-mitigation strategy that should reap benefits all the way through from clinical trials
8-K
EX-99.1
vuomt8iew0
24 Jul 23
Regulation FD Disclosure
4:04pm
424B5
coheejuge0 cbc34lcns
21 Jul 23
Prospectus supplement for primary offering
4:39pm
8-K
EX-99.2
7xz3kg o9t
22 May 23
Regulation FD Disclosure
1:05pm
8-K
EX-99.1
e3dtnhharfug5i4y6
22 May 23
Regulation FD Disclosure
1:05pm
8-K
EX-99.1
v42wmg2
17 Oct 22
Regulation FD Disclosure
5:13pm
8-K
EX-99.1
wtjc9r6p
28 Jun 22
Departure of Directors or Certain Officers
9:46am
DEFA14A
y5is3w9dudlhaz6hw
14 Jun 22
Additional proxy soliciting materials
4:05pm
8-K
EX-99.1
ddypkv2bmq4o6
27 May 22
Regulation FD Disclosure
8:44am